MIMEDX GROUP, INC. Earnings Per Share Disclosure
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net income from continuing operations | $ | 48,578 | $ | 41,998 | $ | 67,439 | |||||||||||
| Income (loss) from discontinued operations, net of tax | — | 421 | (9,211) | ||||||||||||||
| Net income | 48,578 | 42,419 | 58,228 | ||||||||||||||
| Adjustments to reconcile to net income available to common stockholders: | |||||||||||||||||
| Accumulated dividend on previously converted Series B Preferred Stock | — | — | 6,753 | ||||||||||||||
| Preferred share repurchase in excess of book value | — | — | 4,890 | ||||||||||||||
| Total adjustments | — | — | 11,643 | ||||||||||||||
| Net income available to common stockholders from continuing operations | $ | 48,578 | $ | 41,998 | $ | 55,796 | |||||||||||
| Weighted average common shares outstanding | 147,793,069 | 146,979,354 | 116,495,810 | ||||||||||||||
| Basic net income (loss) per common share: | |||||||||||||||||
| Continuing operations | $ | 0.33 | $ | 0.29 | $ | 0.48 | |||||||||||
| Discontinued operations | — | — | (0.08) | ||||||||||||||
Basic net income per common share | $ | 0.33 | $ | 0.29 | $ | 0.40 | |||||||||||
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net income available to common stockholders from continuing operations | $ | 48,578 | $ | 41,998 | $ | 55,796 | |||||||||||
| Adjustments: | |||||||||||||||||
| Dividends on previously converted Series B Preferred Stock | — | — | 6,466 | ||||||||||||||
| Preferred share repurchase in excess of book value | — | — | 5,177 | ||||||||||||||
| Less: antidilutive adjustments | — | — | (5,177) | ||||||||||||||
| Total adjustments | — | — | 6,466 | ||||||||||||||
| Numerator | |||||||||||||||||
| Net income available to common stockholders from continuing operations | 48,578 | 41,998 | 62,262 | ||||||||||||||
| Income (loss) from discontinued operations, net of tax | — | 421 | (9,211) | ||||||||||||||
| Weighted average common shares outstanding | 147,793,069 | 146,979,354 | 116,495,810 | ||||||||||||||
| Adjustments: | |||||||||||||||||
| Potential common shares (a) | |||||||||||||||||
| Previously converted Series B Preferred Stock | — | — | 27,457,905 | ||||||||||||||
| Restricted stock unit awards | 1,252,226 | 1,447,217 | 1,452,153 | ||||||||||||||
| Outstanding stock options | 526,105 | 473,015 | 396,779 | ||||||||||||||
| Performance stock unit awards | 153,107 | 149,611 | 137,425 | ||||||||||||||
| Restricted stock awards | — | — | 22,136 | ||||||||||||||
| Employee stock purchase plan | — | — | 254 | ||||||||||||||
| Total adjustments | 1,931,438 | 2,069,843 | 29,466,652 | ||||||||||||||
| Weighted average common shares outstanding adjusted for potential common shares | 149,724,507 | 149,049,197 | 145,962,462 | ||||||||||||||
| Diluted net income (loss) per common share: | |||||||||||||||||
| Continuing operations | $ | 0.32 | $ | 0.28 | $ | 0.43 | |||||||||||
| Discontinued operations | 0.00 | 0.00 | (0.06) | ||||||||||||||
Diluted net income per common share | $ | 0.32 | $ | 0.28 | $ | 0.37 | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Repurchase of Series B Preferred Stock | — | — | 1,219,348 | ||||||||||||||
Want the next MIMEDX GROUP, INC. earnings per share disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment MIMEDX GROUP, INC.'s next filing hits EDGAR. No credit card, your email never gets sold.
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.